Skip to content

Brought to you by

Dentons On Call

Making health law a little more accessible and a lot less daunting.

open menu close menu

Dentons On Call

  • Home
  • About Us

Government Funding Law Changes Rules Regarding Dual Eligibles and the Medicaid DSH Hospital-Specific Limit

By Charles Luband and Callan Smith
February 9, 2026
  • Hospitals & Health Systems
  • Medicaid
  • Reimbursement
  • US Health Care
Share on Facebook Share on Twitter Share via email Share on LinkedIn

The recent Consolidated Appropriations Act, 2026 (2026 CAA) modified the rules on how costs and payments related to patients eligible for both Medicaid and another payer (“dual-eligible patients”) are included in the hospital-specific limit that sets the maximum amount hospitals can receive in Medicaid disproportionate share hospital (DSH) payments each year.1 The new law updates a change made by Section 203 of the Consolidated Appropriations Act, 2021 (2021 CAA) that resulted in cuts to hospital DSH payments, which itself was preceded by years of litigation.2 The new legislation requires hospitals to include costs and payments related to dual-eligible patients, but only if costs exceed payments.

The legislation creates an opportunity for certain hospitals in certain states to revise DSH payment methodologies for state plan rate years beginning after October 1, 2022 and obtain additional payments related to this new inclusion.

Background

In 2008, CMS published a final rule interpreting new requirements regarding Medicaid DSH reporting. Numerous questions remained and in 2010 CMS provided guidance concerning many aspects of the hospital-specific limit, including with respect to the inclusion of costs and payments related to dual-eligible patients. The 2010 guidance provided that hospitals must include costs and payments related to dual-eligible patients. This position benefited some hospitals (i.e., those whose payments were less than their associated costs) but not others (i.e., those whose payments exceeded their associated costs) and litigation followed, with opinions going both ways. In 2017, CMS promulgated a regulation codifying its 2010 guidance, which regulation largely was upheld by the appellate courts.

Four years later, Congress stepped in and changed the law. The 2021 CAA generally precluded inclusion of costs and payments for dual-eligibles for most hospitals effective October 1, 2021. An exception was made for hospitals in the 97th percentile or above with respect to the number of Medicare supplemental security income (“SSI”) days or percentage of Medicare SSI days to total inpatient days, which were permitted to use the prior methodology and receive the higher amount according to the two calculations.

The New Development

The 2026 CAA changed the law again to specifically allow inclusion of dual-eligible costs, provided they exceed payments, for all hospitals for any state plan rate year beginning after February 3, 2026. The provision eliminates the prior exception, which is no longer relevant. The new law also allows states with unused Medicaid DSH allotments for any state plan rate year after October 1, 2022 to submit state plan amendments to retroactively claim that unused DSH allotment to make payments to cover the newly eligible costs, notwithstanding time limits, as long as the payments are made before the DSH audit report is due.3

The New Opportunity

If you are a hospital with costs related to dual-eligible patients that exceed payments received for those patients, there may be an opportunity to receive additional Medicaid DSH payments in the future, or even related to prior state plan rate years, if there is an unused DSH allotment. If you are interested in investigating further, please contact your Dentons lawyer.


  1. Pub. L. No. 119-75. In addition, the 2026 CAA eliminates two years of DSH allotment reductions previously scheduled to take effect on January 30, 2026; one year of DSH allotment reductions remains in statute, scheduled to begin in federal fiscal year 2028. ↩︎
  2. Pub. L. No. 116-260. ↩︎
  3. Pub. L. No. 119-75, Div. J, Section 6106. ↩︎

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Charles Luband

About Charles Luband

Charles Luband is a partner and former co-chair of Dentons' Health Care practice. He advises a diverse group of health care clients on a variety of federal and state regulatory issues and Medicare and Medicaid issues.

All posts Full bio

Callan Smith

About Callan Smith

Callan J. Smith is a member of the national Health Care group and a resident of the Washington, DC office. He provides strategic counsel to clients navigating complicated federal legislative and regulatory issues, drawing on his decade of experience in Washington, DC.

All posts Full bio

RELATED POSTS

  • Compliance
  • Corporate
  • Fraud & Abuse
  • News Flash
  • US Health Care

States Join Federal Government in Targeting Private Equity in Healthcare

By Danika Rothwell
  • Hospitals & Health Systems
  • Medicaid
  • Medicare
  • Reimbursement

Congressional Check-Up: Comparing Competing Health Care Proposals

By Callan Smith
  • Digital Health
  • Health Care IT
  • Hospitals & Health Systems
  • Managed Care
  • Medicare
  • Reimbursement

CMMI Launches Application Process for ACCESS Model: A New, Outcome-Focused Value-Based Payment Model

By Joanna Borman and Kate Sullivan Morgan

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com

Categories

  • Anti-Kickback Statute
  • Compliance
  • Corporate
  • Corporate Practice of Medicine | CPOM
  • Digital Health
  • Digital IT
  • Fraud & Abuse
  • Health Care IT
  • Hospitals & Health Systems
  • Managed Care
  • Management Services Organizations | MSOs
  • Medicaid
  • Medical Devices
  • Medicare
  • News Flash
  • Pharmaceuticals
  • Podcast
  • Privacy & Security
  • Reimbursement
  • Stark Law
  • US Health Care

Subscribe and stay updated

Receive our latest blog posts by email.

Stay in Touch

© 2026 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site